Alzheimer's Disease Trial, Recruiting NCT07306065 Sponsor: University of Central Florida Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT07306065
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 50 years old or older
  • People who have no mild cognitive impairment (the trial is looking to include 20 people in this group)
  • People who have been diagnosed with mild cognitive impairment (the trial is looking to include 20 people in this group)
  • People who have been diagnosed with Alzheimer's disease or dementia (the trial is looking to include 20 people in this group)
  • People who can read or speak English, or who have a legally authorised representative who can do so on their behalf, and who agree to follow the study procedures
  • Women who are pregnant may choose to take part

Who may not be able to join:

  • People who are 49 years old or younger
  • People who are currently in prison
  • People who are unable to understand English or unable to give their own consent

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kiminobu Sugaya, PhD, University of Central Florida

Phone: 14072668742

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Central Florida
Registry
ClinicalTrials.gov
Start date
28 August 2025
Est. completion
1 March 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Effect of music therapy in Alzheimer's patients by analyzing salivary exosomes

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov